In addition to HER2, expression levels of other antigens in GBM impair the function of HER2-CAR-T because the diversity of GBM cell antigens makes it impossible to identify HER2 antigens, thereby affecting the efficiency of tumor treatment. The gene discussed is ERBB2; the disease is neoplasm.